The global “influenza medication market” size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period. Increasing global burden of influenza will be one of the central forces driving the growth of this market. Influenza, or the flu, is a virus that infects the human respiratory system, that is, the throat, lungs, and nose. Usually, the infection subsides on its own, but sometimes it can turn severe and even prove to be fatal. According to the World Health Organization (WHO), every year influenza epidemics around the globe affect around 3 million to 5 million people and cause respiratory deaths between 290,000 and 650,000. The developed nations are also bearing the impact of this deadly virus. For instance, the US Centers for Disease Control and Prevention (CDC) states that since 2010, the occurrence of influenza-related illnesses in the US have been between 9 million and 45 million. In 2016-17, the CDC estimates that hospitalizations resulting from influenza alone will be around 500,000. Thus, such exponential rise in the prevalence of this infection will raise the influenza treatment market demand in the coming years. In its new report, titled “Influenza Medication Market Size, Share Industry Analysis, By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B), By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026”, Fortune Business Insights™ states that the value of this market stood at USD 889.2 million in 2018. The report also contains:
- Exhaustive research into the different market segments;
- Comprehensive assessment of the various drivers and challenges influencing the market;
- 360-degree analysis of the competitive landscape (company profiles, strategies, and product offerings); and
- Careful study of the regional dynamics shaping the market.
Get Sample PDF Brochure Of Influenza Medication Market Report at:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Influenza Medication Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.
Influenza Medication Market Analysis 2021:
The global Influenza Medications market size is projected to rise remarkably on account of the increasing number of chronic and acute diseases and the advent of technologically advanced procedures to diagnose them. Influenza Medication is an imaging scanner intensifier used for intraoperative imaging in surgical, orthopaedic, or emergency diagnostic procedures owing to its radiographic abilities.
The increasing number of chronic and acute diseases requiring imaging procedures is a crucial factor propelling the Influenza Medications market growth. This, coupled with a rise in the demand for minimally invasive procedures, is also expected to aid in the expansion of the market. Also, the advent of artificial intelligence in radiology for assisting the discovery of genomic markers will boost the market growth in the coming years.
On the contrary, factors such as high cost of Influenza Medications instruments may pose a significant hindrance to the market in the coming years. Nevertheless, they have a wide variety of applications such as urology, vascular, neurovascular, spinal surgery, and others. The increasing demand for Influenza Medication imaging system from the applications listed above is likely to create lucrative growth opportunities for the market in the coming years.
The world economy is facing rough waters owing to the current pandemic of COVID-19. Most of the import-export businesses are at a halt owing to this pandemic. However, we hope to pass this phase soon with government support and measures. We, at Fortune Business Insights, are offering analytical reports on various markets affected by COVID-19. These reports will help investors chalk out the strategic plans for revenue generation in the coming years.
Influenza Medication market is likely to rise at a CAGR of 4.6% and reach USD 2,453.3 million by the end of 2027 from a revenue of USD 1,708.1 million generated in the year 2019. The forecast period is set between 2020 to 2027.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245